Brain fog
A patient-reported pattern of slowed thinking, memory lapses, word-finding trouble, and reduced attention. The clinical term researchers use is "cognitive dysfunction" — and it is one of the most common features described after SARS-CoV-2 infection.
How researchers study it
The patient-coined term is now used widely, but the clinical work uses formal cognitive testing — the Montreal Cognitive Assessment (MoCA), trail-making tests, working-memory tasks, processing-speed measures. In long COVID cohorts, deficits on these tests appear in people whose pre-illness cognition was unremarkable, and the deficits do not always match self-reported severity (Becker et al., JAMA Network Open, 2022, PubMed 35986142).
Proposed mechanisms include neuroinflammation, vascular injury (microclots and endothelial dysfunction), reactivation of latent viruses, and direct effects on glial cells. A 2024 study using cerebrospinal-fluid markers found elevated immune-activation signals in long COVID patients with persistent cognitive symptoms (Apple et al., Nature Medicine, 2024). No single mechanism has been confirmed.
"Brain fog" also predates COVID-19. The NIH NINDS describes cognitive impairment as a core feature of ME/CFS, which shares many features with long COVID. Brain fog in other contexts — chemotherapy ("chemo-brain"), thyroid disease, perimenopause, fibromyalgia — has its own bodies of research with overlapping themes around inflammation, sleep architecture, and energy metabolism.
Common misconceptions
- Becker JH et al. "Assessment of Cognitive Function in Patients After COVID-19 Infection." JAMA Network Open, 2022. PubMed: 35986142
- Apple AC et al. "Neurocognitive and gait abnormalities in long COVID." Nature Medicine, 2024. nature.com
- NIH NINDS. "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome." ninds.nih.gov